Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Weekly Irinotecan Combined With Amrubicin in Previously Treated Small-Cell Lung Cancer

NCT00132054 is registered in ClinicalTrials.gov with Japan Multinational Trial Organization as lead sponsor.

NCT NCT00132054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00132054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Weekly Irinotecan Combined With Amrubicin in Previously Treated Small-Cell Lung Cancer
Lead sponsor
Japan Multinational Trial Organization
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2004
Completion date
November 30, 2008
Enrollment
30 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer